Richard Weaver

5.5k citations

86 papers · 3.9k indexed · 2 hit papers · h-index 36

Impact in

Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Oncology top 2%
- Drug Transport and Resistance Mechanisms

Papers in

Pharmacology 43
- Pharmacogenetics and Drug Metabolism 35
- Drug-Induced Hepatotoxicity and Protection 14
- Antibiotics Pharmacokinetics and Efficacy 7
- Inflammatory mediators and NSAID effects 5
Oncology 29
- Drug Transport and Resistance Mechanisms 27

Co-authors: M.D. Burke S. Thompson C. Roland Wolf William T. Melvin Graeme I. Murray Jean‐Pierre Valentin Maurice Dickins Peter F. Jackson
Journals: Bioorganic & Medicinal Chemistry Letters (9 papers)Toxicology in Vitro (6 papers)Biochemical Pharmacology (6 papers)Toxicology (5 papers)Toxicological Sciences (5 papers)
Partner nations: United Kingdom France United States

In The Last Decade

Richard Weaver

84 papers receiving 3.8k citations

Hit Papers

align trajectories log scale

The evolving role of investigative toxicology in the pharmaceutical industry 2023 · 132 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Reviews Drug Discovery
1994 Biochemical Pharmacology

Peers

Countries citing papers authored by Richard Weaver

Since Specialization

Citations

This map shows the geographic impact of Richard Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Weaver more than expected).

Fields of papers citing papers by Richard Weaver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Weaver. The network helps show where Richard Weaver may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard Weaver Line = papers co-authored together Richard Weaver links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro Toxicology and Applied Pharmacology ·Giulio Giustarini, Szabolcs Nagy, Marco Barra, Angela Oppelt, Occupant Protection, Richard Weaver, Marianne Bol‐Schoenmakers, Joost J. Smit, Bob van de Water, Ursula Klingmüller, Raymond Pieters	2020	12
2	A ligand-induced structural change in fatty acid–binding protein 1 is associated with potentiation of peroxisome proliferator–activated receptor α agonists Journal of Biological Chemistry ·Rahul Patil, Biswaranjan Mohanty, Neil Murphy, Indu R. Chandrashekaran, Stephen J. Headey, M.L. Williams, Craig S. Clements, 李尙馥, B.C. Doak, Brad R. Crawford, Richard Weaver, Laurent Vuillard, Michelle L. Halls, Christopher J. H. Porter, M.J. Scanlon	2019	19
3	Differential toxic effects of bile acid mixtures in isolated mitochondria and physiologically relevant HepaRG cells Toxicology in Vitro ·В.П. Попов, Parveen Sharma, 禎夫木檜, B. Kevin Park, Richard Weaver, Amy E. Chadwick	2019	19
4	A Dynamic Mathematical Model of Bile Acid Clearance in HepaRG Cells Toxicological Sciences ·Daniel Kaschek, Ahmad Sharanek, André Guillouzo, Jens Timmer, Richard Weaver	2017	6
5	Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication Toxicological Sciences ·Rowena Sison‐Young, M.O. Sayin, Rosalind E. Jenkins, David R. Mottram, Eliane Alexandre, Lysiane Richert, 禎夫木檜, Richard Weaver, Robert Jones, Sandra Garcia, Philip Hewitt, Magnus Ingelman‐Sundberg, Christopher E. Goldring, Neil R. Kitteringham, 勝山川	2015	72
6	Quantification of biliary excretion and sinusoidal excretion of 5(6)-carboxy-2′,7′-dichlorofluorescein (CDF) in cultured hepatocytes isolated from Sprague Dawley, Wistar and Mrp2-deficient Wistar (TR−) rats Toxicology in Vitro ·Lucy C.J. Ellis, M.H. Grant, Gabrielle Hawksworth, Richard Weaver	2014	10
7	Discovery of small molecule human FPR1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·John Unitt, Malbinder Fagura, Janine [UNESP] Contro, H. M, Matthew W. D. Perry, Andrew Morley, Cathy MacDonald, Richard Weaver, Muhammed Abdullah Yeter, Andrew Schiro, S A Pedhnekar, Melanie Paul, Andrew Cook, Andrew Baxter	2011	19
8	Synthesis and biological evaluation of N-alkylated 8-oxybenz[c]azepine derivatives as selective PPARδ agonists Bioorganic & Medicinal Chemistry Letters ·Christopher A. Luckhurst, M. Ratcliffe, V Iacobini, Mark Furber, C Briede, David L. Laughton, Wendy Tomlinson, Richard Weaver, Kamaldeep K. Chohan, Andrew Walding	2010	10
9	The immediate early genes, c-fos, c-jun and AP-1, are early markers of platinum analogue toxicity in human proximal tubular cell primary cultures Toxicology in Vitro ·Richard D. Wainford, Richard Weaver, Gabrielle Hawksworth	2009	10
10	Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells Biochemical Pharmacology ·Sandrine Dauchy, Florence Miller, Pierre‐Olivier Couraud, Richard Weaver, Babette B. Weksler, Ignacio A. Romero, Jean‐Michel Scherrmann, Isabelle de Waziers, Xavier Declèves	2008	151
11	Identification and reduction of ion suppression effects on pharmacokinetic parameters by polyethylene glycol 400 Rapid Communications in Mass Spectrometry ·Richard Weaver, Akbar Zainu	2006	57
12	Prediction of interindividual variation in drug plasma levels in vivo from individual enzyme kinetic data and physiologically based pharmacokinetic modeling European Journal of Pharmaceutical Sciences ·Jan J.P. Bogaards, Rosangela Boyd, М. Д. Татищева, Richard Weaver, Roeline Jochemsen, Peter F. Jackson, Marc Bertrand, Peter J. van Bladeren	2000	31
13	A comparison of basal and induced hepatic microsomal cytochrome P450 monooxygenase activities in the cynomolgus monkey (Macaca fascicularis) and man Xenobiotica ·Richard Weaver, Maurice Dickins, M.D. Burke	1999	34
14	An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes Bioorganic & Medicinal Chemistry Letters ·Nareg A. Gharibjanian, T. Nogaku, Michael P. Barrett, Reto Brun, Guillermo Hoyos Velásquez, Alan H. Fairlamb, Richard Weaver, Ian H. Gilbert	1998	36
15	A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes Biochemical Pharmacology ·Richard Weaver, S. Thompson, Graeme C. M. Smith, Maurice Dickins, Clifford R. Elcombe, Richard T. Mayer, M.D. Burke	1994	90
16	Evidence for a new cytochrome P450 form induced by 3-methylcholanthrene in rats Biochemical Pharmacology ·Richard Weaver, B. Dunbar, Maurice Dickins, William T. Melvin, John E. Fothergill, M.D. Burke	1994	5
17	Similar activity of chlorambucil and its spermidine conjugate in the mouse bone marrow micronucleus assay Mutagenesis ·J. Ashby, H. Tinwell, Richard Weaver, Paul M. Cullis	1994	1
18	Xenobiotic metabolising enzyme expression in colonic neoplasia. Gut ·Judith McKay, Graeme I. Murray, Richard Weaver, S. W. B. Ewen, William T. Melvin, M.D. Burke	1993	55
19	Cytochrome P450 2C9 is responsible for hydroxylation of the naphthoquinone antimalarial drug 58C80 in human liver Biochemical Pharmacology ·Richard Weaver, Maurice Dickins, M.D. Burke	1993	36
20	The expression of cytochrome P-450, epoxide hydrolase, and glutathione s-transferase in hepatocellular carcinoma Cancer ·Graeme I. Murray, Takumi Besshi, Richard Weaver, Stanley W. B. Ewen, William T. Melvin, M.D. Burke	1993	50

About Richard Weaver

Richard Weaver is a scholar working on Pharmacology, Oncology, Pharmacology, Biochemistry and Physiology, having authored 86 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (27 papers), Drug-Induced Hepatotoxicity and Protection (14 papers), Computational Drug Discovery Methods (9 papers), Pharmacological Effects and Toxicity Studies (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Glutathione Transferases and Polymorphisms (5 papers) and Inflammatory mediators and NSAID effects (5 papers). The work is most often cited by research in Pharmacology (1.7k citations), Oncology (1.2k citations), Biochemistry (248 citations), Hepatology (195 citations) and Computational Theory and Mathematics (386 citations). Richard Weaver has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include M.D. Burke, S. Thompson, C. Roland Wolf, William T. Melvin, Graeme I. Murray, Jean‐Pierre Valentin, Maurice Dickins, Peter F. Jackson, Jan J.P. Bogaards and Marc Bertrand. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Toxicology in Vitro, Biochemical Pharmacology, Toxicology and Toxicological Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact